The novel approach of the medication represents a exciting advance in the handling of type 2 diabetes. Different to existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide106468.prublogger.com/40827408/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment